Gupta S, Kumari S, Banwalikar J N, Gupta S K
Department of Microbiology, National Institute of Communicable Diseases, Delhi, India.
Tuber Lung Dis. 1995 Oct;76(5):418-24. doi: 10.1016/0962-8479(95)90008-x.
An ELISA assay based on mycobacterial Antigen A60 for the estimation of Mycobacterium-specific immunoglobulins in the serum has been used successfully for the rapid diagnosis of tuberculosis in studies done in the Western countries. There are hardly any similar large scale studies in India.
To evaluate the utility of this ELISA test for rapid diagnosis of different clinical forms of tuberculosis in an adult Indian population.
ELISA test based on mycobacterial antigen A60 (Anda Biologicals, France) was used to estimate specific IgM, IgA and IgG antibodies in the sera obtained from 337 cases of tuberculosis and 131 controls in the population of Delhi (India).
Of the 131 controls, only 9.9% were positive for IgM, 7.6% for IgG, 6.1% for IgA and 9.9% when an IgA and IgG combination was considered. Of 122 cases of active pulmonary tuberculosis, 41% were positive for IgM, 86.8% for IgA, 88.5% for IgG and a very high positivity (98.3%) was seen when IgA and IgG estimations were combined. A relatively low seropositivity was observed in 25 cases of pleural tuberculosis. The corresponding figures in 130 cases of extrapulmonary tuberculosis were 22.3%, 68.4%, 73.8% and 86.15%. When 60 cases of pulmonary tuberculosis who had been successfully treated with antituberculosis drugs were analyzed the rates of seropositivity fell to 11.6%, 46.6%, 58.3% and 66.6% respectively.
Our findings point to a very good sensitivity (91.6%) and specificity (90.0%) of the test when combined IgA and IgG antibody titres are considered, to detect cases of adult tuberculosis. The role of IgM estimation can be restricted to the detection of cases of reactivation of tuberculosis.
在西方国家开展的研究中,一种基于结核分枝杆菌抗原A60的酶联免疫吸附测定(ELISA)法用于检测血清中结核分枝杆菌特异性免疫球蛋白,已成功用于结核病的快速诊断。在印度,几乎没有类似的大规模研究。
评估这种ELISA检测法在成年印度人群中对不同临床类型结核病进行快速诊断的效用。
采用基于结核分枝杆菌抗原A60(法国安达生物制品公司)的ELISA检测法,对从印度德里人群中选取的337例结核病患者和131例对照者的血清中的特异性IgM、IgA和IgG抗体进行检测。
在131例对照者中,IgM阳性率仅为9.9%,IgG为7.6%,IgA为6.1%,IgA和IgG联合检测时为9.9%。在122例活动性肺结核患者中,IgM阳性率为41%,IgA为86.8%,IgG为88.5%,IgA和IgG联合检测时阳性率非常高(98.3%)。25例结核性胸膜炎患者的血清阳性率相对较低。130例肺外结核患者的相应数据分别为22.3%、68.4%、73.8%和86.15%。对60例已成功接受抗结核药物治疗的肺结核患者进行分析时,血清阳性率分别降至11.6%、46.6%、58.3%和66.6%。
我们的研究结果表明,当考虑联合IgA和IgG抗体滴度时,该检测法对检测成年结核病病例具有非常好的敏感性(91.6%)和特异性(90.0%)。IgM检测的作用可局限于检测结核病复发病例。